Clinical trial
Transcranial Photobiomodulation Treatment in Patients With Sickle Cell Disease
NCT06797583 is registered in ClinicalTrials.gov with St. Jude Children's Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transcranial Photobiomodulation Treatment in Patients With Sickle Cell Disease
- Lead sponsor
- St. Jude Children's Research Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- November 30, 2026
- Completion date
- December 31, 2029
- Enrollment
- 60 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
sickle cell disease